HCL and all relevant indications where LUMOXITI will be prescribed
Showing 1 - 25 of >10,000
Moxetumomab Pasudotox-tdfk (LUMOXITI)
Recruiting
- Hairy Cell Leukemia
-
Pueblo, Colorado
- +1 more
Aug 17, 2022
Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)
Active, not recruiting
- Hairy Cell Leukemia
- Moxetumomab Pasudotox-tdfk
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Paramedic Independent Prescribing in Emergency and Urgent Care
Enrolling by invitation
- Paramedic Independent Prescribing
-
Southampton, Hampshire, United KingdomThe University of Southampton
Oct 24, 2023
Opioid Withdrawal, Opioid Craving, Opioid Use Disorder Trial in Baltimore (Epidiolex 100 mg/mL Oral Solution, Cherry Syrup Oral
Completed
- Opioid Withdrawal
- +2 more
- Epidiolex 100 mg/mL Oral Solution
- Cherry Syrup Oral Solution
-
Baltimore, MarylandJohns Hopkins University
Jul 1, 2022
Eylea in Babies Born Too Early Who HaveCondition of Eye Where
Not yet recruiting
- Retinopathy of Prematurity
- +2 more
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, JapanMany locations
Jan 20, 2023
Vericiguat in Korean People With Chronic Heart Failure With
Not yet recruiting
- Chronic Heart Failure With Reduced Ejection Fraction
- Vericiguat (Verquvo, BAY1021189)
-
Multiple Locations, Korea, Republic ofMany Locations
Nov 20, 2023
Study on the Safety and Performance of Ennovate® Cervical
Recruiting
- Spine Fracture
- +4 more
- posterior stabilization for the cervical spine
-
Hamburg, GermanySchön Klinik Hamburg Eilbek
Mar 16, 2022
Antihypertensive Drugs and Statins by Hair Analysis
Not yet recruiting
- Arterial Hypertension
- +4 more
- Hair analysis for drug concentration
-
Verona, ItalyAzienda Ospedaliera Universitaria Integrata Verona
Apr 26, 2022
Chronic Heart Failure With Reduced Ejection Fraction, Worsening Heart Failure Trial in Vadodara, Nashik (Vericiguat (Verquvo,
Recruiting
- Chronic Heart Failure With Reduced Ejection Fraction
- Worsening Heart Failure
- Vericiguat (Verquvo, BAY1021189)
-
Vadodara, Gujarat, India
- +1 more
Jan 16, 2023
Patent Foramen Ovale Trial (PFO closure)
Not yet recruiting
- Patent Foramen Ovale
- PFO closure
- (no location specified)
Nov 27, 2023
Endometriosis Trial in Bursa (Dienogest Pill, Norethindrone Acetate)
Recruiting
- Endometriosis
- Dienogest Pill
- Norethindrone Acetate
-
Bursa, Nilufer, TurkeyUludag University
Jul 25, 2022
Contraception Trial in Hershey (Norethindrone Acetate 5 MG, Norethindrone 0.35 MG)
Recruiting
- Contraception
- Norethindrone Acetate 5 MG
- Norethindrone 0.35 MG
-
Hershey, PennsylvaniaHershey Medical Center
Jan 20, 2023
Called VERI-China, to Learn More About How Well Vericiguat Works
Not yet recruiting
- Chronic Heart Failure With Reduced Ejection Fraction
- Vericiguat (Verquvo, BAY1021189)
- Standard of Care (SoC)
-
Multiple Locations, Many Locations, ChinaChinese Registries
Feb 6, 2023
Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)
Recruiting
- Solid Tumor
- Haematological Malignancy
- Alectinib
- +4 more
-
Belfast, United Kingdom
- +24 more
Jan 31, 2023
'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
Recruiting
- Ovarian Cancer
- +3 more
-
Busan, Korea, Republic of
- +17 more
Jan 9, 2023
Postoperative Pain Management Trial in United States (EXPAREL and bupivacaine HCl, Bupivacaine HCl)
Terminated
- Postoperative Pain Management
- EXPAREL and bupivacaine HCl
- Bupivacaine HCl
-
Gilbert, Arizona
- +14 more
Oct 12, 2021
Dapagliflozin Post Marketing Surveillance in HF and CKD
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Chronic Kidney Disease
-
Busan, Korea, Republic of
- +28 more
Jan 9, 2023
Cabozantinib Post First-line Immuno-oncology Checkpoint
Completed
- Advanced Renal Cell Carcinoma (aRCC)
-
Glasgow, United Kingdom
- +8 more
Jun 30, 2022
Healthy Aging Trial in Copenhagen (Exercise training)
Recruiting
- Healthy Aging
- Exercise training
-
Copenhagen, DenmarkUniversity of Copenhagen
May 31, 2023
Called SMART-Finder to Look for People With Increased Amounts of
Not yet recruiting
- Type 2 Diabetes Mellitus
- Chronic Kidney Disease
- Finerenone (Kerendia, BAY94-8862)
- Type 2 DM drugs
-
Multiple Locations, GermanyMany locations
Jan 13, 2023
Utility Assessment of a Pharmacy-to-Dose Daptomycin
Enrolling by invitation
- Antibiotics Causing Adverse Effects in Therapeutic Use
- Retroactive review of patient data of those receiving a dose of daptomycin
-
Dallas, TexasMethodist Dallas Medical Center
Feb 3, 2022
Local Anesthetic Complication Trial in Ankara (Articaine Hydrochloride + Epinephrine, Lidocaine Hydrochloride + Epinephrine)
Recruiting
- Local Anesthetic Complication
- Articaine Hydrochloride + Epinephrine
- Lidocaine Hydrochloride + Epinephrine
-
Ankara, TurkeyAnkara Yıldırım beyazıt University, Faculty of Dentistry
Aug 30, 2023
Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)
Recruiting
- Ulcerative Colitis
- Thromboembolism
- Tofacitinib
- Infliximab Adalimumab y Golimumab
-
Madrid, SpainHospital Universitario de La Princesa
Aug 2, 2022
Type1 Diabetes Trial in United States (HCL, verapamil 120mg tablet, non-HCL)
Completed
- Type1 Diabetes
- HCL
- +3 more
-
Palo Alto, California
- +5 more
Oct 31, 2022